NEW YORK, July 14 (GenomeWeb News) - The board of directors of Alnylam Pharmaceuticals has approved a rights agreement to ensure that its stockholders receive preferred stock purchase rights in case of certain 'abusive tactics,' the Cambridge, Mass.-based RNAi company said today.
Already have a GenomeWeb or 360Dx account?Login Now.
In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.
An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.
In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.
In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.